EvoNexus Irvine Portfolio Company Zelegent’s Elevoplasty Procedure Receives U.S. Patent

EvoNexus Irvine portfolio company, Zelegent, has announced their Elevoplasty procedure has been patented! Elevoplasty is an advanced medical technique used by sleep specialist otolaryngologists to treat snoring by shortening and stiffening a patient’s soft palate in a simple office-based procedure deigned to be less invasive than today’s surgical options.

“This patent secures Zelegent’s position in the development of advanced, minimally invasive devices for the sleep specialist otolaryngology community to offer patients a novel, minimally-invasive, office-based procedure that requires no general anesthesia, and that may alleviate snoring by shortening, suspending, and stiffening a patient’s soft palate,” said Alexander K. Arrow, MD, Chief Executive Officer of Zelegent, Inc.

Zelegent joined EvoNexus Irvine in 2015. While they were in the incubator, Zelegent were provided with Class A office and lab space, were introduced to potential strategic partners and potential customers, and received exceptional business mentoring.

EvoNexus is Southern California’s leading startup technology incubator and hub for the startup community with locations in San Diego and Irvine. We empower motivated entrepreneurs to turn their transformative ideas into fundable, commercially-viable companies. Its startups enjoy Class A office and lab space provided by California’s leading real estate developer, Irvine Company. EvoNexus is financially and strategically supported by some of the largest multinational corporations in the world. In just over 7 years, EvoNexus portfolio companies have raised over $1.4 billion in funding and outcomes and 22 startups have been acquired.


Press Release